BIOREGENX, INC. (BRGX) Operating margin 2021–2025
BIOREGENX, INC. (BRGX) operating margin by fiscal year — reported operating income divided by reported revenue.
-67.1%FY2025 · since FY2021: -83.1% → -67.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.1% | +905.7 pp |
| FY2024 | -972.7% | -872.8 pp |
| FY2023 | -99.9% | +85.8 pp |
| FY2022 | -185.7% | -102.6 pp |
| FY2021 | -83.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Gross marginBRGX Operating incomeBRGX Operating cash flowBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →